Podcast: Healthcare’s biggest 2025 trends and 2026 predictions
As the healthcare industry embarks on a new year, there are several factors that look set to impact pharmaceutical and…
30 Dec 2025
How one US state is tackling the drug affordability crisis
Drug affordability remains a key priority for the US government as it negotiates with pharma companies to lower individual drug prices and explore reference pricing models. With these efforts underway…
29 Dec 2025
Enriched patient data needed to uncover sex differences in Alzheimer’s trials
Researchers say that women are twice as likely to develop Alzheimer’s disease as men. However, despite recent advances in treatments for the condition, historical biases in clinical trial recruitment have…
24 Dec 2025
Alternative commercialisation models offer lifeline to future of gene therapies
Cell and gene therapies (CGTs) have captured significant interest in the pharma industry, with the modality being explored in multiple disease areas from oncology to autoimmune diseases due to their…
23 Dec 2025
Magazine: Biopharma’s 2025 M&A boom
As we head into the new year, now is the time to look back on the activity seen in the pharma space in 2025 and consider what it can tell us…
22 Dec 2025
Pharma positions itself for 2026 amid an evolving US landscape
After President Donald Trump’s administration took office in early 2025, a series of policy changes have directly impacted the pharma sector. From tariffs and onshoring initiatives to Most Favored Nation…
16 Dec 2025
States consider payment limits to curb prescription drug prices with PDABs
Four weeks into her pregnancy, Jessica Intermill sensed something was wrong when the pain in her fingers wouldn’t subside. What followed was a months-long cycle of specialist visits before a…